世界卫生组织胎儿生长曲线图:概念、研究发现、解读与应用
世界卫生组织基于10个国家1387例低风险孕妇的纵向研究,获得8203组超声测量数据,采用分位数回归建立胎儿生长曲线图;研究发现估计胎儿体重呈非对称分布,胎儿性别、母亲因素和国家对胎儿体重影响各为1-4.5%且随百分位变化,人群间生长轨迹亦有差异。
要点
- 世界卫生组织胎儿生长曲线图基于10国1387例低风险孕妇的8203组超声测量数据建立。
- 估计胎儿体重分布呈非对称性,孕早期<第50百分位变异较宽,孕晚期>第50百分位变异较宽。
- 胎儿性别、母亲身高体重年龄产次及国家各影响胎儿体重1-4.5%,效应随百分位呈梯度变化。
核心结论
- 世界卫生组织胎儿生长曲线图旨在基于非洲、亚洲、欧洲和南美洲人群的低风险妊娠供国际使用。
- 作者认为测试并监测该曲线图性能是否满足本地需求是审慎的,可通过改变截断值或按胎儿性别、母亲因素和人群定制来完善。
- 研究发现的变异强调,在解决公共卫生问题时需要仔细调整的生长曲线图以反映最佳本地生长。
研究设计与样本
- 研究为纵向研究,纳入来自10个国家(阿根廷、巴西、刚果民主共和国、丹麦、埃及、法国、德国、印度、挪威和泰国)的1387例低风险孕妇。
- 研究提供8203组超声测量数据,用于建立常用胎儿测量指标和估计胎儿体重的生长曲线图。
- 采用分位数回归建立胎儿生长曲线图。
主要发现
- 估计胎儿体重在人群中呈非对称分布:孕中期早期<第50百分位胎儿分布较宽,孕晚期>第50百分位变异明显更宽。
- 胎儿性别、母亲因素(身高、体重、年龄和产次)和国家对胎儿体重均有显著影响(各1-4.5%),且效应随百分位呈梯度变化。
- 对母亲协变量调整后,国家作为协变量仍有显著效应,提示种族、文化和地理变异起作用。
- 人群间变异不限于胎儿大小,生长轨迹也存在差异。
- 37周妊娠时估计胎儿体重第5-95百分位为2205-3538克,表明优化母体条件下人类胎儿生长变异显著且 largely 无法用已知因素解释。
关键数值与推荐
- 参与者中位年龄28岁,58%为未产,体重指数正常,无社会经济或营养限制(中位热量摄入1840千卡/天)。
- 分娩中位孕龄39周,出生体重3300克,两者在国家间均有显著差异。
- 37周妊娠时估计胎儿体重第5-95百分位为2205-3538克。
临床怎么用
- 作者建议该曲线图基于非洲、亚洲、欧洲和南美洲人群的低风险妊娠供国际使用。
- 作者认为测试并监测曲线图性能是否满足本地需求是审慎的,可通过改变截断值或按胎儿性别、母亲因素和人群定制来完善。
- 作者强调在解决公共卫生问题时需要仔细调整的生长曲线图以反映最佳本地生长。
局限性
- 参与者具备参加超声检查的能力,因而本质上代表城市人群。
- 人群间变异 largely 无法用常见已知因素解释。
- 作者建议测试并监测曲线图性能是否满足本地需求,并通过改变截断值或定制来完善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ultrasound biometry is an important clinical tool for the identification, monitoring, and management of fetal growth restriction and development of macrosomia. This is even truer in populations in which perinatal morbidity and mortality rates are high, which is a reason that much effort is put onto making the technique available everywhere, including low-income societies. Until recently, however, commonly used reference ranges were based on single populations largely from industrialized countries. Thus, the World Health Organization prioritized the establishment of fetal growth charts for international use. New fetal growth charts for common fetal measurements and estimated fetal weight were based on a longitudinal study of 1387 low-risk pregnant women from 10 countries (Argentina, Brazil, Democratic Republic of Congo, Denmark, Egypt, France, Germany, India, Norway, and Thailand) that provided 8203 sets of ultrasound measurements. The participants were characterized by median age 28 years, 58% nulliparous, normal body mass index, with no socioeconomic or nutritional constraints (median caloric intake, 1840 calories/day), and had the ability to attend the ultrasound sessions, thus essentially representing urban populations. Median gestational age at birth was 39 weeks, and birthweight was 3300 g, both with significant differences among countries. Quantile regression was used to establish the fetal growth charts, which also made it possible to demonstrate a number of features of fetal growth that previously were not well appreciated or unknown: (1) There was an asymmetric distribution of estimated fetal weight in the population. During early second trimester, the distribution was wider among fetuses <50th percentile compared with those above. The pattern was reversed in the third trimester, with a notably wider variation >50th percentile. (2) Although fetal sex, maternal factors (height, weight, age, and parity), and country had significant influence on fetal weight (1-4.5% each), their effect was graded across the percentiles. For example, the positive effect of maternal height on fetal weight was strongest on the lowest percentiles and smallest on the highest percentiles for estimated fetal weight. (3) When adjustment was made for maternal covariates, there was still a significant effect of country as covariate that indicated that ethnic, cultural, and geographic variation play a role. (4) Variation between populations was not restricted to fetal size because there were also differences in growth trajectories. (5) The wide physiologic ranges, as illustrated by the 5th-95th percentile for estimated fetal weight being 2205-3538 g at 37 weeks gestation, signify that human fetal growth under optimized maternal conditions is not uniform. Rather, it has a remarkable variation that largely is unexplained by commonly known factors. We suggest this variation could be part of our common biologic strategy that makes human evolution extremely successful. The World Health Organization fetal growth charts are intended to be used internationally based on low-risk pregnancies from populations in Africa, Asia, Europe, and South America. We consider it prudent to test and monitor whether the growth charts' performance meets the local needs, because refinements are possible by a change in cut-offs or customization for fetal sex, maternal factors, and populations. In the same line, the study finding of variations emphasizes the need for carefully adjusted growth charts that reflect optimal local growth when public health issues are addressed.
引用
- Kiserud T, Benachi A, Hecher K, et al. The World Health Organization fetal growth charts: concept, findings, interpretation, and application. Am J Obstet Gynecol. 2018. PMID: 29422204. doi:10.1016/j.ajog.2017.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。